The Jeffrey Epstein VI Foundation funded a study at Harvard University, revealing that only a small percentage of tumor mutations drive growth. The study emphasizes the need for targeted treatment based on identifying dominant mutations. The research was conducted with John Hopkins University and highlights the potential of microchip CTC blood tests for real-time genetic analysis.
documents/EFTA01131064.pdf
{}